Department of Oncology UNIL CHUV, University of Lausanne, Épalinges, Switzerland.
Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research, University of Lausanne, Épalinges, Switzerland.
Front Immunol. 2020 Feb 27;11:340. doi: 10.3389/fimmu.2020.00340. eCollection 2020.
In the context of adoptive T cell transfer (ACT) for cancer treatment, it is crucial to generate large amounts of tumor-specific CD8 T cells with high potential to persist . PD-1, Tim3, and CD39 have been proposed as markers of tumor-specific tumor-infiltrating CD8 T lymphocytes (CD8 TILs). However, these molecules are highly expressed by terminally differentiated exhausted CD8 T cells (Tex) that lack proliferation potential. Therefore, optimized strategies to isolate tumor-specific TILs with high proliferative potential, such as Tcf1+ precursor exhausted T cells (Tpe) are needed to improve persistence of ACT. Here we aimed at defining cell surface markers that would unequivocally identify Types for precision cell sorting increasing the purity of tumor-specific PD-1+ Tcf1+ Tpe from total TILs. Transcriptomic analysis of Tpe vs. Tex CD8 TIL subsets from B16 tumors and primary human melanoma tumors revealed that Tpes are enriched in and lack and expression, which encode Slamf6, CD39, and Tim3 cell surface proteins, respectively. Indeed, we observed by flow cytometry that CD39- Tim3- Slamf6+ PD-1+ cells yielded maximum enrichment for tumor specific PD-1+ Tcf1+ OT1 TILs in B16.OVA tumors. Moreover, this population showed higher re-expansion capacity upon an acute infection recall response compared to the CD39+ counterparts or bulk PD-1+ TILs. Hence, we report an enhanced sorting strategy (CD39- Tim3- Slamf6+ PD-1+) of Tpes. In conclusion, we show that optimization of CD8 TIL cell sorting strategy is a viable approach to improve recall capacity and persistence of transferred cells in the context of ACT.
在癌症治疗的过继性 T 细胞转移(ACT)中,生成具有高持久性潜力的大量肿瘤特异性 CD8 T 细胞至关重要。PD-1、Tim3 和 CD39 已被提议作为肿瘤浸润性 CD8 T 淋巴细胞(CD8 TIL)的肿瘤特异性标志物。然而,这些分子在缺乏增殖潜力的终末分化耗竭 CD8 T 细胞(Tex)中高度表达。因此,需要优化策略来分离具有高增殖潜力的肿瘤特异性 TIL,例如 Tcf1+前体耗竭 T 细胞(Tpe),以提高 ACT 的持久性。在这里,我们旨在定义细胞表面标志物,这些标志物将明确识别类型,用于精确的细胞分选,从而提高肿瘤特异性 PD-1+Tcf1+Tpe 从总 TIL 中的纯度。Tpe 与 B16 肿瘤和原发性人黑色素瘤肿瘤的 Tex CD8 TIL 亚群的转录组分析表明,Tpe 富含和缺乏和的表达,分别编码 Slamf6、CD39 和 Tim3 细胞表面蛋白。实际上,我们通过流式细胞术观察到 CD39-Tim3-Slamf6+PD-1+细胞从 B16.OVA 肿瘤中产生了最大程度的肿瘤特异性 PD-1+Tcf1+OT1 TIL 富集。此外,与 CD39+对应物或总 PD-1+TIL 相比,该群体在急性感染回忆反应中显示出更高的再扩增能力。因此,我们报告了 Tpe 的增强分选策略(CD39-Tim3-Slamf6+PD-1+)。总之,我们表明优化 CD8 TIL 细胞分选策略是提高 ACT 中转移细胞的召回能力和持久性的可行方法。